SURNF
SureNano Science Ltd. engages in the distribution and sale of surfactant in Canada and the United States. It offers SureNano surfactant, a ready-to-mix food-grade compound that provides the base for high performance nano-emulsions to create homogeneous and stable products. SureNano Science Ltd. was incorporated in 2021 and is headquartered in Vancouver, Canada.
SURNF (SURNF) - Net Assets
Latest net assets as of December 2025: $1.17 Million USD
Based on the latest financial reports, SURNF (SURNF) has net assets worth $1.17 Million USD as of December 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($1.20 Million) and total liabilities ($34.16K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $1.17 Million |
| % of Total Assets | 97.15% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 31.45 |
SURNF - Net Assets Trend (2021–2025)
This chart illustrates how SURNF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SURNF (2021–2025)
The table below shows the annual net assets of SURNF from 2021 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-03-31 | $-79.77K | -295.31% |
| 2024-03-31 | $-20.18K | -107.77% |
| 2023-03-31 | $259.71K | -60.04% |
| 2022-03-31 | $649.95K | -31.55% |
| 2021-03-31 | $949.49K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SURNF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 184216200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (March 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | $1.84 Million | % |
| Total Equity | $-79.77K | 100.00% |
SURNF Competitors by Market Cap
The table below lists competitors of SURNF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Anglo Philippine Holdings Corp
PSE:APO
|
$133.50 |
|
SCOA NIGERIA PLC
XNSA:SCOA
|
$133.60 |
|
Red Capital PLC
LSE:REDC
|
$133.84 |
|
CT UK High Income Trust Plc
LSE:CHIB
|
$134.02 |
|
Apollomics Inc. Warrant
NASDAQ:APLMW
|
$132.88 |
|
Institute of Biomedical Research Corp
PINK:MRES
|
$132.71 |
|
Synergia Energy Ltd.
LSE:SYN
|
$132.62 |
|
CWG PLC
XNSA:CWG
|
$132.18 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SURNF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from -20,180 to -79,773, a change of -59,593.
- Net loss of 59,593 reduced equity.
- Other factors decreased equity by 0.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-59.59K | -74.7% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares SURNF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-03-31 | $0.04 | $0.01 | x |
| 2022-03-31 | $0.03 | $0.01 | x |
| 2023-03-31 | $0.01 | $0.01 | x |
| 2024-03-31 | $0.00 | $0.01 | x |
| 2025-03-31 | $0.00 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SURNF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-80.00%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | -172.12% | -6214.79% | 0.03x | 1.06x | $-1.18 Million |
| 2023 | -147.87% | 0.00% | 0.00x | 1.22x | $-409.99K |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | $-277.87K |
| 2025 | 0.00% | 0.00% | 0.00x | 0.00x | $-51.62K |
Industry Comparison
This section compares SURNF's net assets metrics with peer companies in the Specialty Chemicals industry.
Industry Context
- Industry: Specialty Chemicals
- Average net assets among peers: $7,181,833,981
- Average return on equity (ROE) among peers: 7.11%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SURNF (SURNF) | $1.17 Million | -172.12% | 0.03x | $133.19 |
| AirBoss of America Corp (ABSSF) | $197.00 Million | -16.19% | 1.24x | $57.06 Million |
| Asia Carbon Industries Inc (ACRB) | $19.13 Million | 17.11% | 0.33x | $0.98 |
| Aimia Inc (AIMFF) | $1.29 Billion | -4.63% | 2.83x | $103.68 Million |
| L'Air Liquide S.A (AIQUF) | $11.83 Billion | 14.08% | 1.26x | $107.70 Billion |
| Akzo Nobel N.V (AKZOF) | $7.58 Billion | 14.03% | 1.29x | $9.73 Billion |
| Albemarle Corp (ALB) | $545.00 Million | 9.41% | 1.09x | $19.53 Billion |
| ALPEK S.A.B. de C.V (ALPKF) | $49.59 Billion | 15.64% | 1.50x | $214.40 Million |
| Altech Batteries Limited (ALTHF) | $97.54 Million | -5.87% | 0.01x | $27.89 Million |
| Arcadium Lithium plc (ALTM) | $333.00 Million | 14.14% | 0.12x | $6.26 Billion |
| Alto Ingredients Inc (ALTO) | $345.21 Million | 13.35% | 0.40x | $212.84 Million |